Menü
You need to sign in or sign up before continuing.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Does Johnson & Johnson's Split Make Sense?


Johnson & Johnson (NYSE: JNJ) has been in business for well over a century. Many were blindsided when the company announced late last year that it would be splitting its medical device and pharmaceutical businesses from its consumer health business. The split is set to close sometime in the next two years. In this segment of Backstage Pass, recorded on Dec. 17, Fool.com contributors Rachel Warren, Jason Hall, Travis Hoium, Toby Bordelon, and Lou Whiteman discuss. 

Continue reading


Source Fool.com

Like: 0
JNJ
Teilen

Kommentare